Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
 
Authors :  J. P. Himanen, L. Yermekbayeva, P. W. Janes, J. R. Walker, K. Xu, L. Atapa K. R. Rajashankar, A. Mensinga, M. Lackmann, D. B. Nikolov, S. Dhe-Pag
Date :  06 May 10  (Deposition) - 30 Jun 10  (Release) - 30 Jun 10  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  3.51
Chains :  Asym. Unit :  A,B,C,D
Biol. Unit 1:  A,B  (1x)
Biol. Unit 2:  C,D  (1x)
Keywords :  Ectodomain, Receptor-Ligand Complex, Receptor-Receptor Interaction, Transferase Receptor-Signalling Protein Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  J. P. Himanen, L. Yermekbayeva, P. W. Janes, J. R. Walker, K. Xu, L. Atapattu, K. R. Rajashankar, A. Mensinga, M. Lackmann, D. B. Nikolov, S. Dhe-Paganon
Architecture Of Eph Receptor Clusters.
Proc. Natl. Acad. Sci. Usa V. 107 10860 2010
PubMed-ID: 20505120  |  Reference-DOI: 10.1073/PNAS.1004148107

(-) Compounds

Molecule 1 - EPHRIN TYPE-A RECEPTOR 2
    ChainsA, C
    EC Number2.7.10.1
    EngineeredYES
    Expression SystemHOMO SAPIENS
    Expression System Cell LineHEK-293
    Expression System CommonHUMAN
    Expression System PlasmidPDT101
    Expression System Taxid9606
    Expression System Vector TypePLASMID
    FragmentECTODOMAIN (UNP RESIDUES 27-435)
    GeneEPHA2, ECK
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymTYROSINE-PROTEIN KINASE RECEPTOR ECK, EPITHELIAL CELL KINASE
 
Molecule 2 - EPHRIN-A5
    ChainsB, D
    EngineeredYES
    Expression SystemHOMO SAPIENS
    Expression System Cell LineHEK-293
    Expression System CommonHUMAN
    Expression System Taxid9606
    Expression System Vector TypePLASMID
    FragmentECTODOMAIN (UNP RESIDUES 28-165)
    GeneEFNA5, EPLG7, LERK7
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymEPH-RELATED RECEPTOR TYROSINE KINASE LIGAND 7, LERK-7, AL-1

 Structural Features

(-) Chains, Units

  1234
Asymmetric Unit ABCD
Biological Unit 1 (1x)AB  
Biological Unit 2 (1x)  CD

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (1, 8)

Asymmetric Unit (1, 8)
No.NameCountTypeFull Name
1NAG8Ligand/IonN-ACETYL-D-GLUCOSAMINE
Biological Unit 1 (1, 4)
No.NameCountTypeFull Name
1NAG4Ligand/IonN-ACETYL-D-GLUCOSAMINE
Biological Unit 2 (1, 4)
No.NameCountTypeFull Name
1NAG4Ligand/IonN-ACETYL-D-GLUCOSAMINE

(-) Sites  (8, 8)

Asymmetric Unit (8, 8)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREASN A:407BINDING SITE FOR RESIDUE NAG A 501
2AC2SOFTWAREASN B:37 , ASN B:40 , CYS B:62 , PRO B:63 , HIS B:64 , TYR B:65 , NAG B:402BINDING SITE FOR RESIDUE NAG B 401
3AC3SOFTWARENAG B:401 , NAG B:403BINDING SITE FOR RESIDUE NAG B 402
4AC4SOFTWARETYR B:35 , NAG B:402BINDING SITE FOR RESIDUE NAG B 403
5AC5SOFTWAREGLU C:367 , ASN C:407 , THR C:409BINDING SITE FOR RESIDUE NAG C 501
6AC6SOFTWARETYR D:35 , ASN D:37 , CYS D:62 , PRO D:63 , HIS D:64 , TYR D:65 , NAG D:402BINDING SITE FOR RESIDUE NAG D 401
7AC7SOFTWARENAG D:401 , NAG D:403BINDING SITE FOR RESIDUE NAG D 402
8AC8SOFTWARETYR D:35 , NAG D:402BINDING SITE FOR RESIDUE NAG D 403

(-) SS Bonds  (26, 26)

Asymmetric Unit
No.Residues
1A:70 -A:188
2A:105 -A:115
3A:201 -A:247
4A:230 -A:260
5A:262 -A:273
6A:276 -A:290
7A:293 -A:307
8A:309 -A:325
9A:366 -A:379
10A:369 -A:376
11B:53 -B:164
12B:62 -B:102
13B:90 -B:151
14C:70 -C:188
15C:105 -C:115
16C:201 -C:247
17C:230 -C:260
18C:262 -C:273
19C:276 -C:290
20C:293 -C:307
21C:309 -C:325
22C:366 -C:379
23C:369 -C:376
24D:53 -D:164
25D:62 -D:102
26D:90 -D:151

(-) Cis Peptide Bonds  (4, 4)

Asymmetric Unit
No.Residues
1His A:46 -Pro A:47
2Gly A:171 -Pro A:172
3His C:46 -Pro C:47
4Gly C:171 -Pro C:172

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (3, 6)

Asymmetric Unit (3, 6)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_012035N55KEFNA5_HUMANPolymorphism469062B/DN55K
2UniProtVAR_055989K99NEPHA2_HUMANPolymorphism1058372A/CK99N
3UniProtVAR_042121G391REPHA2_HUMANPolymorphism34192549A/CG391R

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (3, 3)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_012035N55KEFNA5_HUMANPolymorphism469062BN55K
2UniProtVAR_055989K99NEPHA2_HUMANPolymorphism1058372AK99N
3UniProtVAR_042121G391REPHA2_HUMANPolymorphism34192549AG391R

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (3, 3)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_012035N55KEFNA5_HUMANPolymorphism469062DN55K
2UniProtVAR_055989K99NEPHA2_HUMANPolymorphism1058372CK99N
3UniProtVAR_042121G391REPHA2_HUMANPolymorphism34192549CG391R

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (6, 12)

Asymmetric Unit (6, 12)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1EPH_LBDPS51550 Eph receptor ligand-binding domain profile.EPHA2_HUMAN28-206
 
  2A:28-206
C:28-206
2EPHRIN_RBD_2PS51551 Ephrin receptor-binding (ephrin RBD) domain profile.EFNA5_HUMAN29-162
 
  2B:29-162
D:29-162
3EPHRIN_RBD_1PS01299 Ephrin receptor-binding (ephrin RBD) domain signature.EFNA5_HUMAN113-140
 
  2B:113-140
D:113-140
4RECEPTOR_TYR_KIN_V_1PS00790 Receptor tyrosine kinase class V signature 1.EPHA2_HUMAN182-202
 
  2A:182-202
C:182-202
5RECEPTOR_TYR_KIN_V_2PS00791 Receptor tyrosine kinase class V signature 2.EPHA2_HUMAN247-267
 
  2A:247-267
C:247-267
6FN3PS50853 Fibronectin type-III domain profile.EPHA2_HUMAN438-529
328-432
 
  2-
A:328-432
C:328-432
Biological Unit 1 (6, 6)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1EPH_LBDPS51550 Eph receptor ligand-binding domain profile.EPHA2_HUMAN28-206
 
  1A:28-206
-
2EPHRIN_RBD_2PS51551 Ephrin receptor-binding (ephrin RBD) domain profile.EFNA5_HUMAN29-162
 
  1B:29-162
-
3EPHRIN_RBD_1PS01299 Ephrin receptor-binding (ephrin RBD) domain signature.EFNA5_HUMAN113-140
 
  1B:113-140
-
4RECEPTOR_TYR_KIN_V_1PS00790 Receptor tyrosine kinase class V signature 1.EPHA2_HUMAN182-202
 
  1A:182-202
-
5RECEPTOR_TYR_KIN_V_2PS00791 Receptor tyrosine kinase class V signature 2.EPHA2_HUMAN247-267
 
  1A:247-267
-
6FN3PS50853 Fibronectin type-III domain profile.EPHA2_HUMAN438-529
328-432
 
  1-
A:328-432
-
Biological Unit 2 (6, 6)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1EPH_LBDPS51550 Eph receptor ligand-binding domain profile.EPHA2_HUMAN28-206
 
  1-
C:28-206
2EPHRIN_RBD_2PS51551 Ephrin receptor-binding (ephrin RBD) domain profile.EFNA5_HUMAN29-162
 
  1-
D:29-162
3EPHRIN_RBD_1PS01299 Ephrin receptor-binding (ephrin RBD) domain signature.EFNA5_HUMAN113-140
 
  1-
D:113-140
4RECEPTOR_TYR_KIN_V_1PS00790 Receptor tyrosine kinase class V signature 1.EPHA2_HUMAN182-202
 
  1-
C:182-202
5RECEPTOR_TYR_KIN_V_2PS00791 Receptor tyrosine kinase class V signature 2.EPHA2_HUMAN247-267
 
  1-
C:247-267
6FN3PS50853 Fibronectin type-III domain profile.EPHA2_HUMAN438-529
328-432
 
  1-
-
C:328-432

(-) Exons   (5, 10)

Asymmetric Unit (5, 10)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000003584321aENSE00001954971chr1:16482582-16482343240EPHA2_HUMAN1-29292A:27-29
C:27-29
3
3
1.2ENST000003584322ENSE00000827996chr1:16477458-1647739168EPHA2_HUMAN29-51232A:29-51
C:29-51
23
23
1.3ENST000003584323ENSE00001031821chr1:16475542-16474873670EPHA2_HUMAN52-2752242A:52-275 (gaps)
C:52-275 (gaps)
224
224
1.5ENST000003584325ENSE00000827994chr1:16464925-16464770156EPHA2_HUMAN275-327532A:275-327
C:275-327
53
53
1.6ENST000003584326ENSE00000955420chr1:16464680-16464348333EPHA2_HUMAN327-4381122A:327-435 (gaps)
C:327-435 (gaps)
109
109
1.7ENST000003584327ENSE00000955397chr1:16462265-16462150116EPHA2_HUMAN438-476390--
1.8ENST000003584328ENSE00001031787chr1:16461684-16461531154EPHA2_HUMAN477-528520--
1.9bENST000003584329bENSE00001031795chr1:16461062-16460963100EPHA2_HUMAN528-561340--
1.10ENST0000035843210ENSE00000955400chr1:16460410-1646035556EPHA2_HUMAN561-580200--
1.11aENST0000035843211aENSE00001031771chr1:16460101-16459976126EPHA2_HUMAN580-622430--
1.12aENST0000035843212aENSE00000955402chr1:16459863-16459675189EPHA2_HUMAN622-685640--
1.13ENST0000035843213ENSE00000955403chr1:16458934-1645887362EPHA2_HUMAN685-705210--
1.14ENST0000035843214ENSE00000955404chr1:16458768-16458559210EPHA2_HUMAN706-775700--
1.15ENST0000035843215ENSE00000955405chr1:16458365-16458216150EPHA2_HUMAN776-825500--
1.16ENST0000035843216ENSE00000955406chr1:16456914-16456721194EPHA2_HUMAN826-890650--
1.17ENST0000035843217ENSE00001031824chr1:16456084-16455929156EPHA2_HUMAN890-942530--
1.18bENST0000035843218bENSE00001840165chr1:16451815-16450832984EPHA2_HUMAN942-976350--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:406
 aligned with EPHA2_HUMAN | P29317 from UniProtKB/Swiss-Prot  Length:976

    Alignment length:409
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426         
          EPHA2_HUMAN    27 KEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPPGGEEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPSPEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCEQCWPESGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTASVSIN 435
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eeeeee..........ee.......eee..ee..ee..eee..........eeee...ee......eee..eeeee................eeeeeee.............ee........ee.hhhhhh....eee..eee......eee..eee.....eeee.eeeeeee..ee...eee..ee........eeee.ee........--...eeee..................ee......ee....ee.........ee..........................................eeee.....eeeee............eeeeee.....-.......................eeee........eeeeeeee...........eeeeee... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------N---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------R-------------------------------------------- SAPs(SNPs)
                PROSITE (1) -EPH_LBD  PDB: A:28-206 UniProt: 28-206                                                                                                                                             ----------------------------------------RECEPTOR_TYR_KIN_V_2 ------------------------------------------------------------FN3  PDB: A:328-432 UniProt: 328-432                                                                     --- PROSITE (1)
                PROSITE (2) -----------------------------------------------------------------------------------------------------------------------------------------------------------RECEPTOR_TYR_KIN_V_1 ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) 1.1----------------------Exon 1.3  PDB: A:52-275 (gaps) UniProt: 52-275                                                                                                                                                                                  ---------------------------------------------------Exon 1.6  PDB: A:327-435 (gaps) UniProt: 327-438 [INCOMPLETE]                                                 Transcript 1 (1)
           Transcript 1 (2) --Exon 1.2  PDB: A:29-51 -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.5  PDB: A:275-327 UniProt: 275-327            ------------------------------------------------------------------------------------------------------------ Transcript 1 (2)
                 3mx0 A  27 KEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPP--EEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPSPEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCEQCWP-SGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTASVSIN 435
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236 |  |  246       256       266       276       286       296       306       316       326       336       346       356       366    | |376       386       396       406       416       426         
                                                                                                                                                                                                                                             238  |                                                                                                                               371 |                                                              
                                                                                                                                                                                                                                                241                                                                                                                                 373                                                              

Chain B from PDB  Type:PROTEIN  Length:138
 aligned with EFNA5_HUMAN | P52803 from UniProtKB/Swiss-Prot  Length:228

    Alignment length:138
                                    37        47        57        67        77        87        97       107       117       127       137       147       157        
          EFNA5_HUMAN    28 VADRYAVYWNSSNPRFQRGDYHIDVCINDYLDVFCPHYEDSVPEDKTERYVLYMVNFDGYSACDHTSKGFKRWECNRPHSPNGPLKFSEKFQLFTPFSLGFEFRPGREYFYISSAIPDNGRRSCLKLKVFVRPTNSCM 165
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ...eeeee.............eeee....eeeee.................eeeehhhhhhh.......ee..............eeeee.................eeeeee............eeeeee....... Sec.struct. author
                 SAPs(SNPs) ---------------------------K-------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) -EPHRIN_RBD_2  PDB: B:29-162 UniProt: 29-162                                                                                           --- PROSITE (2)
                PROSITE (3) -------------------------------------------------------------------------------------EPHRIN_RBD_1  PDB: B:113-140------------------------- PROSITE (3)
                 Transcript ------------------------------------------------------------------------------------------------------------------------------------------ Transcript
                 3mx0 B  28 VADRYAVYWNSSNPRFQRGDYHIDVCINDYLDVFCPHYEDSVPEDKTERYVLYMVNFDGYSACDHTSKGFKRWECNRPHSPNGPLKFSEKFQLFTPFSLGFEFRPGREYFYISSAIPDNGRRSCLKLKVFVRPTNSCM 165
                                    37        47        57        67        77        87        97       107       117       127       137       147       157        

Chain C from PDB  Type:PROTEIN  Length:406
 aligned with EPHA2_HUMAN | P29317 from UniProtKB/Swiss-Prot  Length:976

    Alignment length:409
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426         
          EPHA2_HUMAN    27 KEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPPGGEEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPSPEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCEQCWPESGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTASVSIN 435
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
           Pfam domains (1) -Ephrin_lbd-3mx0C03 C:28-201                                                                                                                                                   -------------------------------------  -----------------------------------------------------------------------------------------fn3-3mx0C01 C:330-424                                                                          ----------- Pfam domains (1)
           Pfam domains (2) -Ephrin_lbd-3mx0C04 C:28-201                                                                                                                                                   -------------------------------------  -----------------------------------------------------------------------------------------fn3-3mx0C02 C:330-424                                                                          ----------- Pfam domains (2)
         Sec.struct. author ..ee..hhhhh......eee......eeeeeee..eeeeeeeee.........eee...ee......eeeeeee..................eeeeeeee.............eeeeee......hhhhhh......eeeeeee......eeeee......eeee....eee.....ee...eee............eeee.ee........--...eeee..................eeee..eeee....ee.........ee....ee.........ee...........................ee.....eee...............eeeee.....-...........ee...........eeee.......eeeeeee............eeeeee... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------N---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------R-------------------------------------------- SAPs(SNPs)
                PROSITE (1) -EPH_LBD  PDB: C:28-206 UniProt: 28-206                                                                                                                                             ----------------------------------------RECEPTOR_TYR_KIN_V_2 ------------------------------------------------------------FN3  PDB: C:328-432 UniProt: 328-432                                                                     --- PROSITE (1)
                PROSITE (2) -----------------------------------------------------------------------------------------------------------------------------------------------------------RECEPTOR_TYR_KIN_V_1 ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) 1.1----------------------Exon 1.3  PDB: C:52-275 (gaps) UniProt: 52-275                                                                                                                                                                                  ---------------------------------------------------Exon 1.6  PDB: C:327-435 (gaps) UniProt: 327-438 [INCOMPLETE]                                                 Transcript 1 (1)
           Transcript 1 (2) --Exon 1.2  PDB: C:29-51 -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.5  PDB: C:275-327 UniProt: 275-327            ------------------------------------------------------------------------------------------------------------ Transcript 1 (2)
                 3mx0 C  27 KEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPP--EEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPSPEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCEQCWP-SGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTASVSIN 435
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236 |  |  246       256       266       276       286       296       306       316       326       336       346       356       366    | |376       386       396       406       416       426         
                                                                                                                                                                                                                                             238  |                                                                                                                               371 |                                                              
                                                                                                                                                                                                                                                241                                                                                                                                 373                                                              

Chain D from PDB  Type:PROTEIN  Length:138
 aligned with EFNA5_HUMAN | P52803 from UniProtKB/Swiss-Prot  Length:228

    Alignment length:138
                                    37        47        57        67        77        87        97       107       117       127       137       147       157        
          EFNA5_HUMAN    28 VADRYAVYWNSSNPRFQRGDYHIDVCINDYLDVFCPHYEDSVPEDKTERYVLYMVNFDGYSACDHTSKGFKRWECNRPHSPNGPLKFSEKFQLFTPFSLGFEFRPGREYFYISSAIPDNGRRSCLKLKVFVRPTNSCM 165
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
           Pfam domains (1) Ephrin-3mx0D01 D:28-164                                                                                                                  - Pfam domains (1)
           Pfam domains (2) Ephrin-3mx0D02 D:28-164                                                                                                                  - Pfam domains (2)
         Sec.struct. author ...eee...............eeee....eee...................eeeehhhhhhh......eee.................ee.................eeeeee............eeeeee....... Sec.struct. author
                 SAPs(SNPs) ---------------------------K-------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) -EPHRIN_RBD_2  PDB: D:29-162 UniProt: 29-162                                                                                           --- PROSITE (2)
                PROSITE (3) -------------------------------------------------------------------------------------EPHRIN_RBD_1  PDB: D:113-140------------------------- PROSITE (3)
                 Transcript ------------------------------------------------------------------------------------------------------------------------------------------ Transcript
                 3mx0 D  28 VADRYAVYWNSSNPRFQRGDYHIDVCINDYLDVFCPHYEDSVPEDKTERYVLYMVNFDGYSACDHTSKGFKRWECNRPHSPNGPLKFSEKFQLFTPFSLGFEFRPGREYFYISSAIPDNGRRSCLKLKVFVRPTNSCM 165
                                    37        47        57        67        77        87        97       107       117       127       137       147       157        

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 3MX0)

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 3MX0)

(-) Pfam Domains  (3, 6)

Asymmetric Unit
(-)
Clan: E-set (290)
(-)
Family: fn3 (66)
2afn3-3mx0C01C:330-424
2bfn3-3mx0C02C:330-424
(-)
Clan: GBD (153)

(-) Gene Ontology  (90, 96)

Asymmetric Unit(hide GO term definitions)
Chain A,C   (EPHA2_HUMAN | P29317)
molecular function
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0005003    ephrin receptor activity    Combining with an ephrin to initiate a change in cell activity.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0004714    transmembrane receptor protein tyrosine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
    GO:0090630    activation of GTPase activity    Any process that initiates the activity of an inactive GTPase through the replacement of GDP by GTP.
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0006915    apoptotic process    A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
    GO:0048320    axial mesoderm formation    The process that gives rise to the axial mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
    GO:0001568    blood vessel development    The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
    GO:0046849    bone remodeling    The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis.
    GO:0060444    branching involved in mammary gland duct morphogenesis    The process in which the branching structure of the mammary gland duct is generated and organized. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
    GO:0007155    cell adhesion    The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
    GO:0060326    cell chemotaxis    The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
    GO:0030154    cell differentiation    The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
    GO:0016477    cell migration    The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
    GO:0048013    ephrin receptor signaling pathway    The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
    GO:0008630    intrinsic apoptotic signaling pathway in response to DNA damage    A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.
    GO:0030216    keratinocyte differentiation    The process in which a relatively unspecialized cell acquires specialized features of a keratinocyte.
    GO:0070309    lens fiber cell morphogenesis    The process in which the structures of a lens fiber cell are generated and organized. This process occurs while the initially relatively unspecialized cell is acquiring the specialized features of a lens fiber cell. A lens fiber cell is any of the elongated, tightly packed cells that make up the bulk of the mature lens in a camera-type eye.
    GO:0033598    mammary gland epithelial cell proliferation    The multiplication or reproduction of mammary gland epithelial cells, resulting in the expansion of a cell population. Mammary gland epithelial cells make up the covering of surfaces of the mammary gland. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0051898    negative regulation of protein kinase B signaling    Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
    GO:0021915    neural tube development    The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
    GO:0030182    neuron differentiation    The process in which a relatively unspecialized cell acquires specialized features of a neuron.
    GO:0060035    notochord cell development    The process whose specific outcome is the progression of a notochord cell over time, from its formation to its mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
    GO:0014028    notochord formation    The formation of the notochord from the chordamesoderm. The notochord is composed of large cells packed within a firm connective tissue sheath and is found in all chordates at the ventral surface of the neural tube. In vertebrates, the notochord contributes to the vertebral column.
    GO:0048570    notochord morphogenesis    The process in which the anatomical structures of the notochord are generated and organized. The notochord is a mesoderm-derived structure located ventral of the developing nerve cord. In vertebrates, the notochord serves as a core around which other mesodermal cells form the vertebrae. In the most primitive chordates, which lack vertebrae, the notochord persists as a substitute for a vertebral column.
    GO:0001649    osteoblast differentiation    The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
    GO:0030316    osteoclast differentiation    The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0090004    positive regulation of establishment of protein localization to plasma membrane    Any process that increases the frequency, rate or extent of the directed movement of a protein to a specific location in the plasma membrane.
    GO:0036342    post-anal tail morphogenesis    The process in which a post-anal tail is generated and organized. A post-anal tail is a muscular region of the body that extends posterior to the anus. The post-anal tail may aid locomotion and balance.
    GO:0043491    protein kinase B signaling    A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0070372    regulation of ERK1 and ERK2 cascade    Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0045765    regulation of angiogenesis    Any process that modulates the frequency, rate or extent of angiogenesis.
    GO:0043535    regulation of blood vessel endothelial cell migration    Any process that modulates the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
    GO:0033628    regulation of cell adhesion mediated by integrin    Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin.
    GO:0010591    regulation of lamellipodium assembly    Any process that modulates the rate, frequency or extent of the formation of a lamellipodium, a thin sheetlike extension of the surface of a migrating cell.
    GO:0070848    response to growth factor    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
    GO:0001501    skeletal system development    The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
    GO:0007169    transmembrane receptor protein tyrosine kinase signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0001570    vasculogenesis    The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
    GO:0016032    viral process    A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
    GO:0030054    cell junction    A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction, anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix.
    GO:0042995    cell projection    A prolongation or process extending from a cell, e.g. a flagellum or axon.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005925    focal adhesion    Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005622    intracellular    The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
    GO:0031258    lamellipodium membrane    The portion of the plasma membrane surrounding a lamellipodium.
    GO:0031256    leading edge membrane    The portion of the plasma membrane surrounding the leading edge of a motile cell.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0032587    ruffle membrane    The portion of the plasma membrane surrounding a ruffle.

Chain B,D   (EFNA5_HUMAN | P52803)
molecular function
    GO:0045499    chemorepellent activity    Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a lower concentration of that signal.
    GO:0046875    ephrin receptor binding    Interacting selectively and non-covalently with an ephrin receptor.
    GO:0005168    neurotrophin TRKA receptor binding    Interacting selectively and non-covalently with the neurotrophin TRKA receptor.
    GO:0005169    neurotrophin TRKB receptor binding    Interacting selectively and non-covalently with the neurotrophin TRKB receptor.
    GO:0005170    neurotrophin TRKC receptor binding    Interacting selectively and non-covalently with the neurotrophin TRKC receptor.
    GO:0030297    transmembrane receptor protein tyrosine kinase activator activity    Binds to and increases the activity of a transmembrane receptor protein tyrosine kinase.
biological process
    GO:0007171    activation of transmembrane receptor protein tyrosine kinase activity    Any process that initiates the activity of the inactive transmembrane receptor protein tyrosine kinase activity.
    GO:0006915    apoptotic process    A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
    GO:0007411    axon guidance    The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
    GO:0030154    cell differentiation    The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
    GO:0048668    collateral sprouting    The process in which outgrowths develop from the shafts of existing axons.
    GO:0048013    ephrin receptor signaling pathway    The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0050919    negative chemotaxis    The directed movement of a motile cell or organism towards a lower concentration of a chemical.
    GO:1900025    negative regulation of substrate adhesion-dependent cell spreading    Any process that stops, prevents or reduces the frequency, rate or extent of substrate adhesion-dependent cell spreading.
    GO:0007399    nervous system development    The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
    GO:0048672    positive regulation of collateral sprouting    Any process that activates or increases the frequency, rate or extent of collateral sprouting.
    GO:0050731    positive regulation of peptidyl-tyrosine phosphorylation    Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
    GO:0001934    positive regulation of protein phosphorylation    Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
    GO:0051965    positive regulation of synapse assembly    Any process that activates, maintains or increases the frequency, rate or extent of synapse assembly, the aggregation, arrangement and bonding together of a set of components to form a synapse.
    GO:0043087    regulation of GTPase activity    Any process that modulates the rate of GTP hydrolysis by a GTPase.
    GO:0032956    regulation of actin cytoskeleton organization    Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
    GO:0022604    regulation of cell morphogenesis    Any process that modulates the frequency, rate or extent of cell morphogenesis. Cell morphogenesis is the developmental process in which the shape of a cell is generated and organized.
    GO:0022407    regulation of cell-cell adhesion    Any process that modulates the frequency, rate or extent of attachment of a cell to another cell.
    GO:0051893    regulation of focal adhesion assembly    Any process that modulates the frequency, rate or extent of focal adhesion formation, the establishment and maturation of focal adhesions.
    GO:0061178    regulation of insulin secretion involved in cellular response to glucose stimulus    Any process that modulates the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose.
    GO:0070507    regulation of microtubule cytoskeleton organization    Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins.
    GO:0031290    retinal ganglion cell axon guidance    The process in which the migration of an axon growth cone of a retinal ganglion cell (RGC) is directed to its target in the brain in response to a combination of attractive and repulsive cues.
cellular component
    GO:0031362    anchored component of external side of plasma membrane    The component of the plasma membrane consisting of the gene products that are tethered to the external side of the membrane only by a covalently attached anchor, such as a lipid group embedded in the membrane. Gene products with peptide sequences that are embedded in the membrane are excluded from this grouping.
    GO:0031225    anchored component of membrane    The component of a membrane consisting of the gene products that are tethered to the membrane only by a covalently attached anchor, such as a lipid group that is embedded in the membrane. Gene products with peptide sequences that are embedded in the membrane are excluded from this grouping.
    GO:0005901    caveola    A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Gly A:171 - Pro A:172   [ RasMol ]  
    Gly C:171 - Pro C:172   [ RasMol ]  
    His A:46 - Pro A:47   [ RasMol ]  
    His C:46 - Pro C:47   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  3mx0
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  EFNA5_HUMAN | P52803
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  EPHA2_HUMAN | P29317
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  2.7.10.1
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  EFNA5_HUMAN | P52803
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  EPHA2_HUMAN | P29317
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        EFNA5_HUMAN | P528032x11 4bk5 4bka 4l0p 4m4r
        EPHA2_HUMAN | P293171mqb 2e8n 2k9y 2kso 2x10 2x11 3c8x 3czu 3fl7 3hei 3hpn 3kka 3mbw 3skj 4p2k 4pdo 4trl 5ek7 5i9u 5i9v 5i9w 5i9x 5i9y 5i9z 5ia0 5ia1 5ia2 5ia3 5ia4 5ia5 5njz 5nk0 5nk1 5nk2 5nk3 5nk4 5nk5 5nk6 5nk7 5nk8 5nk9 5nka 5nkb 5nkc 5nkd 5nke 5nkf 5nkg 5nkh 5nki

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 3MX0)